Scotland business

Galashiels firm ProStrakan signs US cancer drug deal

Borders firm ProStrakan has signed a £13.4m deal to acquire exclusive US rights to sell and market a breast cancer drug.

The Galashiels-based company said Fareston would sit well alongside other treatments it offers.

The deal, with US firm GTx, allows ProStrakan to market, distribute and sell the product in America.

The drug will continue to be manufactured and supplied by Finland's Orion Corporation.

More on this story

Related Internet links

The BBC is not responsible for the content of external Internet sites